December 25, 2014 4:49 PM ET

Healthcare Equipment and Supplies

Company Overview of Lumenis Ltd.

Company Overview

Lumenis Ltd, together with its subsidiaries, develops and commercializes energy-based medical systems. The company operates in three segments: Surgical, Ophthalmic, and Aesthetic. The Surgical segment offers various surgical laser systems and accessories used for urology/genitourinary and ENT to hospitals, outpatient clinics, ambulatory surgery centers, and medical practices. The Ophthalmic segment sells ophthalmology laser systems and accessories, such as laser links, slit lamp microscopes, laser indirect ophthalmoscopes, physician eye safety filters, surgical laser probes, and others to ophthalmic practices, outpatient clinics, and ophthalmology departments of hospitals, primarily for use ...

Yokneam Industrial Park

PO Box 240

Yokneam,  2069204

Israel

Founded in 1991

1,061 Employees

Phone:

972 4 959 9000

Fax:

972 4 959 9050

Key Executives for Lumenis Ltd.

Lumenis Ltd. does not have any Key Executives recorded.

Lumenis Ltd. Key Developments

Lumenis Ltd. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Revises Earnings Guidance for the Full Year Ending December 31, 2014

Lumenis Ltd. announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. Total revenue in the third quarter of 2014 was $74.2 million, an increase of 9.4% compared to revenue of $67.8 million last year. On a constant currency basis, total revenue increased 10% year-over-year. Total revenue growth was driven by growth in Aesthetics and Surgical segments, partially offset by declines in Ophthalmic segment. Third quarter 2014 GAAP operating income was $7.1 million, an increase of $0.5 million, or 8.4%, compared to GAAP operating income of $6.6 million last year. Third quarter 2014 GAAP net income was $5.5 million, an increase of $2.1 million, compared to $3.4 million last year. GAAP net income per diluted share was $0.15 in the third quarter of 2014 compared to $0.11 last year, based on 35.8 million and 30.0 million diluted shares outstanding respectively. Third quarter 2014 non-GAAP operating income was $8.0 million, an increase of $0.8 million, or 11.7%, compared to non-GAAP operating income of $7.2 million last year. Third quarter 2014 adjusted EBITDA was $10.2 million, an increase of $1.5 million, or 16.4%, compared to $8.7 million last year. Third quarter 2014 non-GAAP net income was $6.0 million, an increase of $0.3 million, or 4.2%, compared to $5.7 million last year. Non-GAAP net income per diluted share was $0.17 in the third quarter of 2014 compared to $0.19 last year based on 35.8 million and 30.2 million diluted shares outstanding respectively. Net cash provided by operating activities was $2,537,000 against $6,604,000 a year ago. Purchase of property and equipment was $893,000 against $1,039,000 a year ago. For the nine months, total revenues were $212,487,000, operating income was $13,830,000 and net income was $5,905,000 or $0.17 per diluted share against total revenues of $194,262,000, operating income of $19,314,000 and net income of $12,691,000 or $0.43 per diluted share a year ago. Net cash provided by operating activities was $5,556,000 against $23,271,000 a year ago. Purchase of property and equipment was $3,049,000 against $2,549,000 a year ago. Non GAAP operating income was $17,383,000 against $13,872,000 a year ago. Adjusted EBITDA was $22,704,000 against $18,116,000 a year ago. Non-GAAP net income was $12,860,000 or $0.37 per diluted share against $9,430,000 or $0.32 per diluted share a year ago. For the full year ending December 31, 2014, the company expects to report: Revenue in a range of $285 to $287 million, representing an increase of 7% to 8% year-over-year. This compares to a range of $284 million to $287 million previously. Adjusted EBITDA in a range of $29.6 to $30.6 million, representing an increase of 14% to 18% year-over-year. This compares to a range of $29.1 million to $30.6 million previously. Non-GAAP net income in a range of $18.1 to $19.6 million, representing an increase of 22% to 32% year-over-year, and non-GAAP EPS of $0.51 to $0.55.

Lumenis Ltd. to Report Q3, 2014 Results on Nov 11, 2014

Lumenis Ltd. announced that they will report Q3, 2014 results After-Market on Nov 11, 2014

Lumenis Ltd., Q3 2014 Earnings Call, Nov 12, 2014

Lumenis Ltd., Q3 2014 Earnings Call, Nov 12, 2014

Similar Private Companies By Industry

Company Name Region
Telesense Ltd. Middle East/Africa
Tius Elcon Ltd. Middle East/Africa
Orgenics, Ltd. Middle East/Africa
Contec Medical, Ltd. Middle East/Africa
Sync-Rx, Ltd. Middle East/Africa

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Lumenis Ltd., please visit www.lumenis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.